KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer
Journal article published in 2020 by
Sofia Mastoraki 
,
Ioanna Balgkouranidou,
Emily Tsaroucha,
Apostolos Klinakis ,
Vassilis Georgoulias,
Evi Lianidou
,
Ioanna Balgkouranidou,
Emily Tsaroucha,
Apostolos Klinakis ,
Vassilis Georgoulias,
Evi Lianidou
This paper is made freely available by the publisher.
Full text: Download
Data provided by 